Home › Breast Cancer › Georgia › Augusta
Breast Cancer clinical trials in Augusta, GA
5 studies for Breast Cancer are looking for participants at sites in and around Augusta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- Augusta University Georgia Cancer Center, Augusta
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Augusta Oncology Associates PC-D'Antignac, Augusta
- Augusta Oncology Associates PC-Wheeler, Augusta
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecruitingPhase 1
- Georgia Cancer Center at Augusta University, Augusta
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RecruitingPhase 2
- Augusta University, Augusta
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RecruitingPhase 1/2
- Georgia Cancer Center at Augusta University, Augusta
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. Learn about the types, diagnosis, and treatments.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY144 studies
- Houston, TX126 studies
- Boston, MA110 studies
- Nashville, TN78 studies
- Los Angeles, CA73 studies
- Edison, NJ70 studies
- Queens, NY67 studies
- Durham, NC63 studies
- St. Louis, MO63 studies
- Chicago, IL59 studies
- Dallas, TX54 studies
- Philadelphia, PA51 studies
Other studies in Augusta
- Acute Myeloid Leukemia9 studies
- Ovarian Cancer8 studies
- Endometrial Cancer8 studies
- Cancer (all types)7 studies
- Sickle Cell Disease5 studies
- Cervical Cancer5 studies
- Blood Cancers4 studies
- Chronic Myeloid Leukemia4 studies
- Burkitt Lymphoma4 studies
- Non-Hodgkin Lymphoma4 studies
- Diffuse Large B-Cell Lymphoma4 studies
- Leukemia3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.